SCHEMBL16609332

SCHEMBL16609332

Nc1ccc(CCN(C[C@H](O)c2ccccc2)C(=O)Cc2csc(N)n2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB3 P13945 6/20 0.52
ADRB2 P07550 3/20 0.43
ADRB1 P08588 2/20 0.43
NOS1 P29475 1/20 0.43
GABRA5 P31644 1/20 0.41
GABRB2 P47870 1/20 0.41
HSD17B10 Q99714 1/20 0.41
CYP2D6 P10635 1/20 0.40
SLC6A4 P31645 1/20 0.40
KCNH2 Q12809 1/20 0.40
CACNA1C Q13936 1/20 0.40
SCN5A Q14524 1/20 0.40
AOC3 Q16853 1/20 0.35
KDM4E B2RXH2 3/20 0.35
ALDH1A1 P00352 2/20 0.35
HDAC1 Q13547 1/20 0.35
HDAC6 Q9UBN7 1/20 0.35
TAAR1 Q96RJ0 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28729986 1.00 ADRB3 (0.52) ADRB3ADRB2ADRB1NOS1GABRA5
SCHEMBL21952232 0.89 ADRB3 (0.69) ADRB3ADRB2ADRB1CYP2D6SLC6A4
SCHEMBL16609338 0.89 ADRB3 (0.69) ADRB3ADRB2ADRB1CYP2D6SLC6A4
SCHEMBL29610257 0.88 ADRB3 (0.58) ADRB3ADRB2ADRB1NOS1CYP2D6
SCHEMBL16609242 0.86 ADRB3 (0.43) ADRB3ADRB2ADRB1NOS1GABRA5
SCHEMBL15994158 0.82 ADRB3 (0.70) ADRB3ADRB2ADRB1NOS1CYP2D6
SCHEMBL6621610 0.82 ADRB3 (0.70) ADRB3ADRB2ADRB1NOS1CYP2D6
SCHEMBL28986807 0.81 ADRB3 (0.68) ADRB3ADRB2ADRB1CYP2D6SLC6A4
SCHEMBL28986806 0.81 ADRB3 (0.68) ADRB3ADRB2ADRB1CYP2D6SLC6A4
SCHEMBL28729983 0.80 ADRB3 (0.57) ADRB3ADRB2ADRB1CYP2D6SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015044965-A1 A PROCESS FOR PREPARATION OF MIRABEGRON AND ALPHA CRYSTALLINE FORM THEREOF MEGAFINE PHARMA (P) LTD. (IN) 2015-04-02 WO disclosed